中国P站

The integration of microarray and RNA-Seq data has significantly advanced the identification of novel diagnostic biomarkers for hepatocellular carcinoma. This approach has been instrumental in revealing key genes and pathways implicated in tumor progression, thereby offering promising avenues for early detection strategies [1].

Systematic reviews and meta-analyses leveraging microarray-based gene expression profiling are crucial for synthesizing findings in complex diseases like Alzheimer's disease. Such comprehensive analyses consistently pinpoint altered genes and biological pathways, providing deeper insights into disease mechanisms and suggesting potential therapeutic targets [2].

Microarray transcriptomic profiling serves as a powerful tool for elucidating host-pathogen interactions. Its application in dengue virus infection, for instance, has successfully identified specific immune response genes activated during the viral assault, thereby contributing to a clearer understanding and potential antiviral interventions [3].

Beyond gene expression, serum protein microarray profiling represents an emerging method for discovering biomarkers, particularly in autoimmune diseases. This technique is valuable for identifying disease-specific protein signatures, which can significantly aid in precise diagnosis and effective monitoring of disease progression [4].

The utility of gene expression profiling extends to highly aggressive cancers like glioblastoma, where microarray analysis has uncovered potential therapeutic targets. By identifying dysregulated genes and pathways contributing to tumor growth, this method provides novel strategies for drug development and patient treatment [5].

Understanding the host immune response in severe infectious diseases is critical, as demonstrated by microarray analysis of peripheral blood mononuclear cells from COVID-19 patients. This research revealed distinct gene expression patterns, pinpointing potential drug targets by clarifying the inflammatory pathways involved in disease severity [6].

Epigenetic modifications, such as DNA methylation, are increasingly recognized for their role in metabolic health. DNA methylation microarray analysis of adipose tissue from obese individuals has identified specific epigenetic marks linked to various metabolic complications, thereby illuminating underlying molecular mechanisms [7].

In agricultural biotechnology, transcriptional profiling using microarrays offers significant advantages for improving crop resilience. Studies in maize under abiotic stress conditions have identified key genes involved in drought tolerance, providing invaluable genetic resources for developing more robust and resilient crop varieties [8].

The early and accurate diagnosis of acute myocardial infarction remains a clinical priority. Microarray-based gene expression profiling has been successfully utilized to identify novel diagnostic biomarkers, uncovering specific gene signatures that can improve early detection and enhance patient management strategies [9].

Addressing the growing challenge of antibiotic-resistant bacterial infections necessitates a deeper understanding of host defense mechanisms. Microarray profiling investigating host gene expression changes has revealed crucial insights and identified potential targets for adjunct therapies aimed at combating antimicrobial resistance [10].

Description

A study on hepatocellular carcinoma utilized an integrated approach combining microarray and RNA-Seq data to pinpoint diagnostic biomarkers. This research successfully identified several key genes and intricate pathways associated with tumor progression, providing a foundation for developing new early detection methods and targeted therapies for this aggressive cancer [1]. A systematic review and meta-analysis focused on Alzheimer's disease meticulously synthesized findings from various microarray-based gene expression profiling studies. This extensive work effectively highlighted consistently altered genes and crucial biological pathways, thereby significantly contributing to the understanding of disease mechanisms and offering novel insights for therapeutic development [2]. Researchers investigating dengue virus infection employed microarray transcriptomic profiling to comprehensively characterize the host immune response. This methodology allowed for the identification of specific genes activated during the infection process, offering valuable insights into complex host-pathogen interactions and potential targets for future antiviral interventions [3]. The development of serum protein microarray profiling as a tool for autoimmune disease biomarker discovery was explored, demonstrating its significant potential. This method proved highly effective in identifying unique, disease-specific protein signatures, which are essential for advancing both the accurate diagnosis and the effective long-term monitoring of autoimmune conditions [4]. In the context of glioblastoma, gene expression profiling through microarray analysis was instrumental in uncovering novel therapeutic targets. The study specifically identified dysregulated genes and associated pathways that are crucial contributors to tumor growth and progression, thereby paving the way for innovative drug development strategies against this challenging brain cancer [5]. An investigation into severe COVID-19 cases utilized microarray analysis of peripheral blood mononuclear cells to delineate distinct gene expression patterns. This analysis was key to understanding the nuanced host immune response and identifying specific inflammatory pathways, ultimately revealing potential drug targets to mitigate the severity of the disease [6]. The application of DNA methylation microarray analysis to human adipose tissue from obese individuals led to the identification of specific epigenetic marks. These marks were found to be significantly associated with various aspects of metabolic health, providing critical molecular insights into the complex mechanisms underlying obesity-related complications and potential interventions [7]. For enhancing agricultural resilience, transcriptional profiling using microarrays was conducted on maize plants subjected to abiotic stress. This research successfully identified key genes that confer drought tolerance, offering invaluable genetic resources that can be leveraged in breeding programs to develop crop varieties more resistant to adverse environmental conditions [8]. To improve the diagnosis of acute myocardial infarction, microarray-based gene expression profiling was employed to discover novel biomarkers. This study successfully identified unique gene signatures that could potentially lead to earlier and more accurate detection, thus enabling more timely and effective patient management strategies following cardiac events [9]. The global challenge of antibiotic-resistant bacterial infections was addressed through microarray profiling, which examined host gene expression changes. This investigation provided crucial insights into host defense mechanisms activated in response to resistant pathogens, thereby identifying potential targets for adjunct therapies designed to combat and overcome antimicrobial resistance [10].

Conclusion

Microarray technology continues to be a pivotal tool in biomedical and agricultural research, offering comprehensive insights into gene and protein expression patterns across various biological contexts. Recent studies highlight its utility in identifying novel diagnostic and therapeutic biomarkers for a range of human diseases. For instance, integrated microarray and RNA-Seq analyses have pinpointed key genes in hepatocellular carcinoma and glioblastoma, while systematic reviews have leveraged microarray data to understand Alzheimer's disease mechanisms. The technology is also crucial for characterizing immune responses to infections, such as dengue virus and severe COVID-19, and for investigating host defense mechanisms against antibiotic-resistant bacteria. Furthermore, microarray profiling extends to epigenetic studies, revealing DNA methylation patterns linked to metabolic health in obesity, and to protein analysis for autoimmune disease biomarkers. In agriculture, it aids in identifying genes for drought tolerance in maize, contributing to crop improvement. The consistent application of microarray-based expression profiling underscores its vital role in advancing early detection, refining patient management, and developing new therapeutic and agricultural strategies.

References

1. Meng L, Chunmei L, Xintong H. (2023) .Biomolecules 13:785.

   , ,

2. Yuancai M, Yi L, Mengran W. (2021) .Front. Aging Neurosci. 13:757835.

   , Google Scholar,

3. Surasit W, Preeyaporn S, Sunchai S. (2023) .Viruses 15:627.

   , ,

4. Qianqian F, Yuanyuan Y, Fangzhou H. (2022) .J. Immunol. Methods 508:113303.

   , ,

5. Liang Y, Wen L, Jiawei L. (2023) .Front. Pharmacol. 14:1201944.

   , ,

6. Mariya G, Elena S, Alexander K. (2022) .Int. J. Mol. Sci. 23:7098.

   , ,

7. Juan MC, Rosa C, Mariona J. (2022) .Clin. Epigenetics 14:22.

   , ,

8. Lijuan W, Weimin T, Xiangli T. (2023) .Plants (Basel) 12:2549.

   , ,

9. Yu Z, Xin W, Yuhang H. (2022) .BMC Cardiovasc. Disord. 22:221.

   , ,

10. Shuxian Y, Mingze L, Yanyan L. (2021) .Infect. Genet. Evol. 95:105021.

    , ,